Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11 clinical trials
Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men

There are currently no published studies addressing drug-drug interactions (DDI) between masculinizing hormone therapy (MHT) and pre-exposure prophylaxis (PrEP) among transgender men (TGM). This could lead to concerns and subsequent prioritizing MHT over PrEP among TGM. Because tenofovir alafenamide (TAF) can achieve higher intracellular tenofovir diphosphate (TFV-DP) levels with lower …

  • 0 views
  • 26 Jan, 2021
  • 1 location
Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'

" to start ART against pragmatic and practical safe initiation of treatment needs to be tested using currently available safe potent antiretroviral agents in a head-to-head comparison study to allow

antiretroviral agents
antiretroviral therapy
darunavir
AIDS
emtricitabine
  • 0 views
  • 24 Jun, 2021
  • 3 locations
Catalysing the Containment of COVID-19

profile. No clinically significant interactions are expected with commonly used antihypertensive agents, anti-diabetics drugs, antiretroviral agents, steroids or commonly prescribed analgesics/anti

nitazoxanide
cough
antihypertensive drugs
oseltamivir
respiratory distress
  • 42 views
  • 14 Jun, 2021
  • 4 locations
7-valent Pneumococcal Conjugated Vaccination

Hypothesis: the efficacy of 2 doses 7-valent PCV is equivalent to 1 dose 7-valent PCV.

  • 0 views
  • 07 Nov, 2020
The Detection of Drug-Resistant HIV-1 in Taiwan

To assess the HIV resistance rate to variable antiretroviral agents in Taiwan, especially in patients with treatment failure, and to know the correlation between the drug resistance

antiretroviral therapy
antiretroviral agents
  • 3 views
  • 07 Nov, 2020
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Due to the potential for pregnancy-induced changes in the pharmacokinetics of medication, one cannot assume that the currently licensed doses of the medication to be tested under this protocol lead to adequate exposure in an HIV-infected pregnant woman. For the agents under study no or limited pharmacokinetic data during pregnancy …

antiretroviral agents
haart
antiretroviral
hiv antibodies
immune globulin
  • 156 views
  • 19 Jul, 2021
  • 25 locations
Risk of Morbidity Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV

HIV infection is now a chronic disease in countries where antiretroviral treatments (ART) are largely available. Long-term follow-up is required to describe and understand the evolution of morbidities and complications as well as new treatments side effects. The main objective of the cohort is to describe and study the evolution …

antiretroviral
HIV Vaccine
antiretroviral agents
  • 2 views
  • 12 Sep, 2021
  • 41 locations
Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir

A total of 1900 pregnant women in the 1st trimester (633 women living with HIV (WLHIV) initiating Dolutegravir (DTG)-based antiretroviral therapy (ART) in pregnancy, 633 WLHIV continuing DTG use from pre-pregnancy, and 634 women without HIV) and their children will be enrolled and followed for two years. As part of …

insulin resistance
hiv viral load
antiretroviral therapy
dolutegravir
emtricitabine
  • 0 views
  • 13 Aug, 2021
  • 2 locations
A Long-term Follow-up of the HIV-NAT Cohort

With HIV/AIDS increasingly considered a chronic disease, 24-, or 48-week data from antiretroviral studies are no longer sufficient. Only with long-term follow-up and outcome data will shed some much-needed light on the answers of questions that have stumped us for several years. Data from a large observational cohort of patients …

hiv viral load
HIV Vaccine
antiretroviral agents
antiretroviral therapy
AIDS
  • 2 views
  • 25 Jan, 2021
  • 1 location
Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy (the PEDAL Study)

. Dual-drug combinations offer the advantage of a reduced exposure to antiretroviral agents, therefore leading to potential reductions in drug-associated side effects in the long-term. In light of this

darunavir
dolutegravir
antiretroviral
raltegravir
HIV Vaccine
  • 0 views
  • 13 Aug, 2021
  • 1 location